Sanofi Divests Enjaymo Rights to Recordati in a $825 Million Deal
Oct 5, 2024
Pharmaceuticals Stock Market Invest
Alembic Pharma's Panelav Facility Receives EIR from USFDA, Indicating Positive Outlook
Sep 29, 2024
Dupixent® (dupilumab) Becomes First Biologic Approved in China for COPD Treatment – A Major Milestone for Regeneron Pharmaceuticals
Sep 28, 2024
Undervalued Stocks Positioned for a Rise with Potential Federal Reserve Interest Rate Reductions
Sep 25, 2024
AstraZeneca Pharma Secures CDSCO Approval to Import Innovative Cancer Drug Durvalumab
Sep 24, 2024
Novartis Kisqali® Demonstrates 28.5% Reduction in Early Breast Cancer Recurrence Risk
Sep 16, 2024
SciSparc Ltd. Provides Additional Funding to AutoMax in a Strategic Bridge Loan Move
Sep 12, 2024
Positive Results for Dupixent in Phase 3 Study for CSU Patients
Sep 12, 2024
Clearmind Medicine Discloses Innovative MDMA-Based Therapy Publication
Sep 6, 2024
Biocon Subsidiary Receives USFDA Approval for Generic Chronic Heart Failure Drug
Sep 2, 2024
Cytokinetics Reveals Encouraging Safety Data on Aficamten at ESC Congress 2024
Sep 1, 2024
Government Crackdown on Fixed Dose Combination Drugs Rattles Pharmaceutical Sector
Aug 22, 2024
Recursion Pharmaceuticals Strengthens Position by Aligning with Exscientia
Aug 19, 2024
Cingulate Inc. Secures European Patent for ADHD Medication CTx-1301
Aug 15, 2024
Recursion and Exscientia Merge to Forge a Trailblazing Drug Discovery Engine
Aug 8, 2024
Novo Nordisk Reports Patients Maintain Wegovy Treatment for Six Months Amid Limited Supply
Aug 8, 2024
Novo Nordisk Reports Extended Use of Wegovy Due to Limited Supply
Aug 7, 2024
GENFIT Announces Positive EMA Opinion on Iqirvo® for Primary Biliary Cholangitis
Jul 26, 2024
Eli Lilly and Company Shares Dip Amid Competition from Roche's Weight Loss Drug Data
Jul 19, 2024
Silo Pharma Joins Forces with Resyca BV for Intranasal PTSD Treatment Development
Jul 19, 2024
Pieris Pharmaceuticals PIRS Receives a Neutral 'Hold' Rating from StockNews.com Analysts
Jul 4, 2024
Dupixent® (dupilumab) Becomes First Targeted Therapy in EU for COPD Patients with Elevated Eosinophils
Jul 3, 2024
SpringWorks Therapeutics Submits NDA for Mirdametinib to the FDA
Jul 2, 2024
Recursion Pharmaceuticals' Stock Slide Following Public Offering Announcement
Jun 28, 2024
Quoin Pharmaceuticals Announces Sponsorship of the FIRST 2024 National Conference
Jun 26, 2024
New Study Highlights Effectiveness of Inhaled Insulin for Type 1 Diabetes Management
Jun 23, 2024
Alvotech and STADA Amplify Strategic Alliance with New Denosumab Biosimilar Partnership
Jun 12, 2024
Ipsen's Iqirvo® Granted Accelerated FDA Approval for Primary Biliary Cholangitis Treatment
Jun 11, 2024
Emergent BioSolutions Inc. Addresses Opioid Crisis and Honors National Naloxone Awareness
Jun 7, 2024
Corbus Pharmaceuticals Reports Promising Results for SYS6002 in Nectin-4 Positive Tumor Treatment
Jun 2, 2024
FDA Prioritizes Review of Dupixent for COPD with Type 2 Inflammation, a Potential Breakthrough by Regeneron and Sanofi
Jun 1, 2024
Mirum Pharmaceuticals Showcases Promising LIVMARLI Data at ESPGHAN Meeting
May 19, 2024
MannKind Gains FDA Approval to Commence Phase 3 Trials for NTM Treatment
Apr 30, 2024
Health Canada Approves VELSIPITY™ for Adults with Ulcerative Colitis
Apr 24, 2024
XORTX Therapeutics Reports 2023 Milestones and Preps for Key Clinical Trial
Mar 19, 2024
Novo Nordisk A/S Announces Share Repurchase Programme
Mar 19, 2024
Wegovy® Gains FDA Approval for Cardiovascular Risk Reduction in Overweight or Obese Patients with Cardiovascular Disease
Mar 9, 2024
Clearmind Medicine Announces Submission of Three New Psychedelic Patent Applications
Feb 27, 2024
Clearmind Medicine Announces Submission of Three New Psychedelic Patent Applications
Feb 27, 2024
Amylyx Pharmaceuticals Investor Notification: Potential Lead Plaintiff Window Open for Significant Losses
Feb 18, 2024
Incannex Advances Tobacco Cessation Aids with FDA Pre-IND Success for CannQuit-N
Feb 17, 2024
Cancer Supportive Care Drugs Market Set for Steady Growth, Predicted to Reach USD 16.7 billion by 2031
Feb 13, 2024
Investor Rights Firm Holzer & Holzer, LLC Files Class Action Lawsuit Against Amylyx Pharmaceuticals, Inc. (AMLX)
Feb 13, 2024
Pharma Leads Earnings Surges in Q3, Boosting Resilience on National Stock Exchange
Feb 5, 2024
Infosys Stock Demonstrates Market Dominance with Notable Share Price Surge
Jan 17, 2024
Clarivate Highlights Thirteen Drugs with Blockbuster Potential in 2023 Report
Jan 9, 2024
Innovative Psychedelic Treatments for TBI Show Promise: A Look at Recent Developments
Jan 8, 2024
Ibogaine's Potential in TBI Therapy Gains Momentum Amid Psychedelic Investment Wave
Jan 8, 2024
Isomorphic Labs and Novartis Forge $37.5 Million Research Collaboration on Drug Discovery
Jan 7, 2024
FDA Completes Review of Amgen's Supplemental Application for LUMAKRAS® (sotorasib)
Dec 27, 2023
Pre-Market Surge for ReShape Lifesciences as FDA Approves Lap-Band 2.0 FLEX; Multiple Stocks on the Move
Dec 14, 2023
GENFIT Highlights NIS2+™ as a Potent Screening Tool in Liver Disease Clinical Trials
Dec 7, 2023
Arvinas and Pfizer Reveal Advanced Vepdegestrant Data at 2023 SABCS
Nov 29, 2023
EMA Initiates Expedited Review of Valneva's Candidate Chikungunya Vaccine
Nov 28, 2023
Supernus Pharmaceuticals SUPN Receives Hold Rating After Previous Buy Position
Nov 18, 2023
Eagle Pharmaceuticals EGRX Receives a Hold Rating from StockNews.com Amid Market Evaluations
Nov 16, 2023
Amphastar Pharmaceuticals AMPH Receives Stock Rating Upgrade amid Expanding Market Presence
Nov 15, 2023
Pomerantz Law Firm Probes Investor Claims Against Amylyx Pharmaceuticals
Nov 14, 2023
4 Pharma Giants with the Resilience to Overcome Industry Challenges
Nov 14, 2023
Four Prominent Pharma Stocks Poised to Overcome Industry Challenges
Nov 14, 2023